Clinical Research Institute of Michigan – Shores Rheumatology
Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201
- Indication: Rheumatoid Arthritis
- Enrollment Status: Closed
- Protocol: PRIMA-102 “Aqtual”
- Drug: N/A: Collection for Assessment of DMARD Initiation
- Sponsor: Aqtual
- Description: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with inadequate response or intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD